This inventor holds 6 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Enterome S.a.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Francesco Strozzi: Innovator in Cancer Immunotherapy
Introduction
Francesco Strozzi is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer immunotherapy, focusing on innovative methods to enhance the immune response against tumors. With a total of 6 patents to his name, Strozzi is recognized for his groundbreaking work in identifying microbiota sequence variants that can be utilized in anticancer medicaments.
Latest Patents
Strozzi's latest patents include "Microbiota sequence variants of tumor-related antigenic epitopes." This invention relates to cancer immunotherapy and provides a method for identifying microbiota sequence variants of tumor-related antigenic epitope sequences. These variants are crucial for developing anticancer medicaments, as they differ from self-antigens and can elicit a robust immune response. Another notable patent is "Immunogenic compounds for cancer therapy," which involves an immunogenic compound comprising an antigenic peptide with amino acid similarity to a tumor antigen. This compound is selected from a specific group of sequences described in the patent.
Career Highlights
Francesco Strozzi has established himself as a key figure in the field of cancer research. His work at Enterome S.A. has been instrumental in advancing the understanding of tumor immunology and developing new therapeutic strategies. His innovative approaches have the potential to transform cancer treatment and improve patient outcomes.
Collaborations
Strozzi collaborates with notable colleagues, including Laurent Chene and Christophe Bonny. These partnerships enhance the research and development efforts at Enterome S.A., fostering a collaborative environment that drives innovation in cancer therapy.
Conclusion
Francesco Strozzi's contributions to cancer immunotherapy through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic options that could significantly impact cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile